Background: There is no clear consensus on the preference for pharmacological
cardioversion (PC) in comparison to electric cardioversion (EC) for hemodynamically stable …

AIMS: To assess the effectiveness and to identify predictors for successful electrical
cardioversion (ECV) and maintenance of sinus rhythm, in long term follow up of patients with …

Background Electrical cardioversion (ECV) is routinely used to restore sinus rhythm in
patients with symptomatic atrial fibrillation. The European guidelines have been updated in …

Objectives We retrospectively analyzed the predictive factors of successfully electrical
cardioversion in patients with chronic atrial fibrillation. Methods We included 118 patients …

Background Cardioversion is a class I procedure for patients with symptomatic atrial
fibrillation (AF) pursuing rhythm control. There are few contemporary reports on quality of life …

Objectives: This study was designed to determine the characteristics and outcomes of
spontaneous conversion (SC) to sinus rhythm (SR) in patients with atrial fibrillation (AF) of …

Background: Modern personalised medicine requires patient-tailored decisions. This is
particularly important when considering pharmacological cardioversion for the acute …

A rhythm control strategy based on a combination of antiarrhythmic drugs and electrical
cardioversion (s) has emerged as a viable alternative for treatment of atrial fibrillation …

Background Strategies to restore sinus rhythm in patients with atrial fibrillation (AF) lasting
less than 48 h with haemodynamic stability remain controversial. The aim of this study was …

Results from clinical trials suggest that antiarrhythmic drugs (AD) can facilitate electrical
cardioversion (EC) for persistent atrial fibrillation (AF)(duration> 48 hours, no spontaneous …